OptiMoM Grows Up: 5.5-year Follow-up of the OptiMoM Fortifier Study
Launched by THE HOSPITAL FOR SICK CHILDREN · Mar 11, 2020
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children who were enrolled in the Bovine vs. Human Milk-Based Fortifier Study (NCT02137473)
- • Children who were born \>=37 weeks gestation and weighing \> 2500g \[Term-born comparison group\]
- Exclusion Criteria:
- • For term-born comparison only: a child with any chromosomal or congenital anomaly affecting growth
About The Hospital For Sick Children
The Hospital for Sick Children (SickKids) is a leading pediatric health care and research institution located in Toronto, Canada. With a commitment to advancing child health through innovative research, education, and clinical care, SickKids is recognized globally for its expertise in pediatric medicine. The hospital actively sponsors clinical trials aimed at improving treatment outcomes and enhancing the quality of life for children with various health conditions. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, SickKids strives to translate research findings into tangible advancements in pediatric care, ensuring that children receive the best possible treatments based on the latest scientific evidence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials